PMS21 - BUDGET IMPACT MODEL OF INCLUSION OF TOFACITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN FRANCE

Authors :: S. Roze
A. Granghaud
M. Pignata
C. Huyghe Garassus
A. Dubanchet
H. Ben Chaabane
C. Masia
Source :: Value in Health. 21:S291
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: medicine.medical_specialty
Tofacitinib
business.industry
Health Policy
Rheumatoid arthritis
Internal medicine
Public Health, Environmental and Occupational Health
medicine
Budget impact
medicine.disease
business
Inclusion (education)

Tools